• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

Not taking mRNA vaccines? One more angmoh vaccine coming your way from big pharma. Sponsored by USA operation warp speed grant one

The factory in Tuas Biomedical Park can produce three or four different types of vaccines simultaneously, as compared with current industrial sites which usually allow for the production of only one vaccine at any one time, Sanofi noted.
This is because the new facility will tap digital technologies and single-use systems (SUSs) in vaccine manufacturing, said Sanofi Pasteur senior vice-president Vincent Hingot, who is also head of global vaccines industrial affairs.
SUSs allow multiple vaccines to be made in a single suite at reduced costs, among other benefits.
 
Meanwhile, the gov sg propaganda has reached a whole new level. :biggrin:

Take note of the number of dislikes on the video. :wink:

 
The facility will be able to leverage multiple vaccine manufacturing technology platforms based on different cell types.

Sanofi did not elaborate on what vaccines will be manufactured in the new plant, which has the capabilities to manufacture both cell culture-based vaccines and mRNA vaccines.

Construction of the factory is slated to begin in the third quarter of 2021. It is expected to be fully operational in the first quarter of 2026, once all qualifications and validations of the first manufactured vaccine have been completed.
 
"This new site will provide Sanofi with the ability to produce innovative vaccines on a massive scale in Asia for Asia, with the flexibility and the agility to quickly respond to future pandemic risks," said Mr Hingot.

The capacity of the facility, which will be a regional centre of excellence for vaccine production in Asia, could also be expanded in the future with the right level of partnership in Asia, he added.

The firm's new investment in Singapore follows its recent commitment to build a new facility in Canada, which will increase the global supply of its Fluzone high-dose influenza vaccine.

Economic Development Board chairman Beh Swan Gin noted that when completed, Sanofi's facility in Singapore will be one of the most technologically advanced vaccine-manufacturing facilities globally.

Such a production facility is a very important infrastructure that will enable not just Singapore, but also the region to address future pandemics and health crises, he added.

At the same time, the facility will also contribute to Singapore's ambitions in advanced manufacturing in the pharmaceutical sector. Dr Beh said: "So this will also create opportunities for local companies to co-develop new solutions with Sanofi to help the facility evolve and challenge the boundaries of advanced manufacturing for years to come."

In a Facebook post, Trade and Industry Minister Chan Chun Sing said that when the facility is complete in 2026, it will, along with other pharmaceutical firms’ facilities here, contribute to Singapore’s capabilities in end-to-end production of almost all kinds of vaccines.

“It will make us more resilient, physically and economically. It will also strengthen our position as part of the global vaccine value chain,” he said.
 
Singapore is home to Sanofi's Asia headquarters, regional export centre and a manufacturing plant in Tuas for pharmaceutical products. More than 400 employees are based here and work across various fields, including clinical research.

Besides working on two Covid-19 vaccine candidates separately with GlaxoSmithKline (GSK) and Translate Bio, Sanofi is also providing manufacturing support to Johnson & Johnson and BioNTech, which have successfully developed Covid-19 vaccines.

The biomedical manufacturing cluster was a linchpin of Singapore's manufacturing growth in 2020, and output rose 24 per cent for the full year on the back of strong performance in the pharmaceuticals and medical technology segments.

It contributed 4.2 percentage points to the manufacturing sector's rise in 2020, behind only the key electronics sector.

Many of the world's largest pharma companies, including GSK, Pfizer and Roche, have set up research and development as well as manufacturing hubs here.
 
Its too late as market already cornered.
It’s not too late as they are targeting the booster market in 2022 for their vaccine to be able to be used as booster regardless of initial vaccine received.
Sanofi also confirmed it would begin clinical studies in the coming weeks to assess the efficacy of the vaccine as a booster, regardless of what vaccine a subject may have received first.
 
"In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus, while a second stage will evaluate a second formulation targeting the B.1.351 virus," Sanofi said.

The virus lineage known as B.1.351 was first detected in South Africa.

"Recent scientific evidence shows that antibodies created against the B.1.351 variant may provide broad cross-protection against other more transmissible variants," Sanofi said.

"The design of the Phase III, conducted across a broad diversity of geographies, also allows evaluation of the efficacy of the candidate against a variety of circulating variants," the French drugmaker added in a statement
May provide protection against the most transmissible Indian variant too.
 
Darling, are you vaccinated?
You are quite a risk given your popularity..
You evil filthy coward Malaysian indian liar son of whore when are you going to learn courage from Jeff Bezos not scared to die swear if I am not what you said be burnt to death?
 
Sam, they have to join Telegram SG vaccine injuries to know more. Can u please give them the link as i am unable to?
Seriously after what happened to me nowadays I only trust those from immediate circle of people I know. Anything on Internet can be fake twisted to suit evil filthy liar sons of whores evil racist terrorist whatever agenda.
 
Meanwhile, the gov sg propaganda has reached a whole new level. :biggrin:

Take note of the number of dislikes on the video. :wink:


What’s the use of vaccination if still need to wear mask everywhere and it doesn’t protect against the most transmissible Indian variant?
 
What’s the use of vaccination if still need to wear mask everywhere and it doesn’t protect against the most transmissible Indian variant?

That's a good question. Maybe annual booster shots? Like updating your phone software every year. :biggrin:

"Together we can overcome." :roflmao:

 
Seriously I also know of someone who got a very minor stroke a few weeks after taking the vaccine.
That's why it is better not to vaccinate. Not that vaccination can help u immune from covid19. My brother suffers muscle cramps every day after 2 shots of pfizer.
 
That's why it is better not to vaccinate. Not that vaccination can help u immune from covid19. My brother suffers muscle cramps every day after 2 shots of pfizer.
It depends whether you want to take the risk of being seriously ill from covid. For me i will not.
 
OIC sanofi is building a new factory in Tuas. Welcome French researchers!

Pharma giant Sanofi investing in $638m vaccine production centre in Singapore
https://www.straitstimes.com/busine...m-euro-vaccine-production-centre-in-singapore
No, ang mo will not be involved much most likely. as mentioned if you know science you will realise the vaccine produced the technology is totally identical to the one GSK is producing. GSK is mass hiring now, so most of us suspect this current mass hiring is because of this collaboration. So high likely they will be using existing GSK plant to train the scientist now, once the plant is ready, it will be up and running immediately as everyone is trained. it make more sense to second existing professional from GSK over.
 
Back
Top